All Pharma News
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study

Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
Ned Pagliarulo BIOPHARMADIVE
19 Apr 2024
Share Share
Upadacitinib`s Phase 3 GCA Study Met Primary Endpoint

Upadacitinib`s Phase 3 GCA Study Met Primary Endpoint
PR NEWSWIRE
18 Apr 2024
Share Share
AbbVie`s Rinvoq passes muster in yet another autoimmune disease

AbbVie`s Rinvoq passes muster in yet another autoimmune disease
Eric Sagonowsky FIERCE PHARMA
18 Apr 2024
Share Share
AbbVie inks deal for Medincell`s long-acting injectable platform worth up to $1.9B

AbbVie inks deal for Medincell`s long-acting injectable platform worth up to $1.9B
PRESS RELEASE
17 Apr 2024
Share Share
Boehringer Ingelheim plots 25 new launches over the next decade

Boehringer Ingelheim plots 25 new launches over the next decade
Zoey Becker FIERCE PHARMA
16 Apr 2024
Share Share
AbbVie: Atogepant Long-Term Migraine Data At AAN

AbbVie: Atogepant Long-Term Migraine Data At AAN
PR NEWSWIRE
12 Apr 2024
Share Share
SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne

SkinMedica® Empowers Clear Skin Confidence with a New, Modern Approach to Acne
PR NEWSWIRE
09 Apr 2024
Share Share
US FDA declines to approve Supernus` Parkinson`s combination again

US FDA declines to approve Supernus` Parkinson`s combination again
REUTERS
09 Apr 2024
Share Share
AbbVie to Host First-Quarter 2024 Earnings Conference Call

AbbVie to Host First-Quarter 2024 Earnings Conference Call
PR NEWSWIRE
04 Apr 2024
Share Share
Boehringer to lay off salespeople as Humira biosimilar sales lag

Boehringer to lay off salespeople as Humira biosimilar sales lag
Patrick Wingrove REUTERS
04 Apr 2024
Share Share